Travere Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of TVTX for the last quarter is 41.37 M USD, and it's 8.18% lower compared to the previous quarter. The net income of Q1 24 is -136.06 M USD.